Holen Sie sich die Stockscreener-App
178.67
0.09%
-0.14
Handel nachbörslich:
178.67
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt MASI?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$178.81
Offen:
$178.685
24-Stunden-Volumen:
517.11K
Relative Volume:
0.40
Marktkapitalisierung:
$9.36B
Einnahmen:
$1.56B
Nettoeinkommen (Verlust:
$216.80M
KGV:
122.54
EPS:
1.458
Netto-Cashflow:
$206.10M
1W Leistung:
-0.08%
1M Leistung:
+0.01%
6M Leistung:
+24.10%
1J Leistung:
+19.00%
1-Tages-Spanne:
$178.51
$178.78
1-Wochen-Bereich:
$178.35
$178.89
52-Wochen-Spanne:
$125.94
$179.00
Masimo Corp Stock (MASI) Company Profile
Firmenname
Masimo Corp
Sektor
Branche
Telefon
949-297-7000
Adresse
52 DISCOVERY, IRVINE, CA
Compare MASI vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MASI
Masimo Corp
|
178.67 | 9.36B | 1.56B | 216.80M | 206.10M | 1.458 |
ABT
Abbott Laboratories
|
86.66 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
312.95 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
77.59 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.66 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.56 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Masimo Corp Stock (MASI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-27 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2025-11-17 | Eingeleitet | BofA Securities | Neutral |
| 2024-12-27 | Bestätigt | Raymond James | Outperform |
| 2024-11-06 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2024-06-03 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-04-15 | Hochstufung | Stifel | Hold → Buy |
| 2024-03-25 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-01-30 | Herabstufung | Jefferies | Buy → Hold |
| 2024-01-03 | Herabstufung | Needham | Buy → Hold |
| 2023-11-08 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-07-18 | Herabstufung | Stifel | Buy → Hold |
| 2023-07-10 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-02-22 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2022-12-15 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-12-05 | Bestätigt | Needham | Buy |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-09-15 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2022-09-14 | Eingeleitet | Loop Capital | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-02-18 | Hochstufung | Needham | Hold → Buy |
| 2022-02-16 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-10-12 | Fortgesetzt | Raymond James | Mkt Perform |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-08-14 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-04-20 | Herabstufung | Needham | Buy → Hold |
| 2020-03-02 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-05-07 | Bestätigt | Needham | Buy |
| 2019-04-16 | Herabstufung | BTIG Research | Buy → Neutral |
| 2019-03-13 | Bestätigt | Needham | Buy |
| 2018-12-19 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-09-14 | Eingeleitet | Needham | Buy |
| 2018-03-09 | Eingeleitet | Barclays | Overweight |
| 2017-08-14 | Hochstufung | BTIG Research | Neutral → Buy |
| 2017-04-04 | Bestätigt | Wedbush | Outperform |
| 2017-03-16 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-02-27 | Bestätigt | Wedbush | Outperform |
| 2017-02-13 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2016-08-04 | Bestätigt | Wedbush | Outperform |
| 2016-05-05 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2016-05-05 | Bestätigt | Wedbush | Outperform |
| 2016-01-06 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2015-08-05 | Bestätigt | ROTH Capital | Buy |
Alle ansehen
Masimo Corp Aktie (MASI) Neueste Nachrichten
Masimo Corp at JPMorgan Healthcare Conference Transcript - GuruFocus
Wearables in Pharma & Biotech Research and Forecasts Report 2026-2031, Company Profiles and Market Strategies of Abbott, Dexcom, and Masimo - Yahoo Finance
WATER ISLAND CAPITAL LLC's Masimo Corp(MASI) Holding History - GuruFocus
Masimo Corp stock (US5747951003): earnings, Danaher deal and what’s next for the medical-tech spec - AD HOC NEWS
Danaher Masimo Deal Shifts Growth Outlook And Investor Focus - Yahoo Finance
Pentwater discloses 3.18M-share stake in Masimo (MASI) - Stock Titan
[SCHEDULE 13G] MASIMO CORP Passive Investment Disclosure (>5%) - Stock Titan
Joe Kiani holds 3.66M shares of Masimo (NASDAQ: MASI), cites disputed awards - Stock Titan
MASI Stock Price, Quote & Chart | MASIMO CORP (NASDAQ:MASI) - ChartMill
All eyes on Masimo earnings amid pending Danaher takeover - Investing.com
Swedbank AB Sells 8,000 Shares of Masimo Corporation $MASI - MarketBeat
Comerica Bank Lowers Stock Holdings in Masimo Corporation $MASI - MarketBeat
Masimo Shareholder Notice - TMX Newsfile
Masimo Corporation (MASI) Rose Following the Acquisition Announcement - Yahoo Finance
Masimo Shareholder Action Reminder - TMX Newsfile
Wilson Asset Management International PTY Ltd. Increases Stock Position in Masimo Corporation $MASI - MarketBeat
Masimo Corporation Q1 2026 Financial Results: Revenue, Net Income, and Key Financial Highlights - Minichart
Masimo Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Masimo Corp (FRA:3M4) Stock Price & 30 Year Financial Data - GuruFocus
Masimo : Quarterly Report for Quarter Ending April 4, 2026 (Form 10-Q) - marketscreener.com
Masimo Corp. stockholders adopted Danaher merger agreement May 1 - MLex
Masimo Corp 1Q 2026: Revenue $403.6M, Net income $57.1M, EPS $1.09— 10-Q Summary - TradingView
Danaher to acquire Masimo (NASDAQ: MASI) in $180 per share cash deal - Stock Titan
Masimo Corporation Reports Earnings Results for the First Quarter Ended April 04, 2026 - marketscreener.com
Masimo (MASI) director gets new RSU grant and converts prior award - Stock Titan
Masimo (MASI) director awarded 1,119 RSUs and exercises 1,225 units - Stock Titan
Masimo (MASI) chair exercises 1,225 RSUs and receives 1,119-unit grant - Stock Titan
Masimo (MASI) CHRO nets RSU shares after tax-withholding share disposition - Stock Titan
Vanguard Group Inc. Sells 461,225 Shares of Masimo Corporation $MASI - MarketBeat
Masimo Shareholders Approve $180 Per Share Acquisition by Danaher, Merger Expected to Close in 2026 - Minichart
Masimo shareholders give green light to $10B acquisition by Danaher - MassDevice
Masimo Shareholders Approve $9.9B Sale to Danaher - Orange County Business Journal
Masimo shareholders approve its $9.9B acquisition by Danaher - Modern Healthcare News
Masimo Shareholders OK $9.9B Merger Deal with Danaher - Medical Product Outsourcing
Masimo shareholders approve $180 per share Danaher acquisition - Investing.com
Masimo Shareholders Approve Acquisition by Danaher - marketscreener.com
Masimo (NASDAQ: MASI) shareholders back $180 cash acquisition by Danaher - Stock Titan
Masimo nears Danaher sale after shareholder vote backs cash merger - Stock Titan
Masimo Corporation $MASI Shares Purchased by UBS Group AG - MarketBeat
Is Masimo Corporation (MASI) A Good Stock To Buy Now? - Yahoo Finance
Danaher deal finalized: Company to acquire Masimo for $9.9 billion in cash - MSN
MASI SEC FilingsMasimo Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Masimo (MASI) 10-K/A adds governance, CEO pay terms and Danaher merger plans - Stock Titan
Masimo SET Shows Accurate Pulse Oximetry in Newborns of All Skin Tones - Yahoo Finance
MSN Money - MSN
BlackRock (MASI) holds 116,871 shares of Masimo — 0.2% stake - Stock Titan
Masimo Corporation (NASDAQ:MASI) Short Interest Update - MarketBeat
M&T Bank Corp Purchases 6,578 Shares of Masimo Corporation $MASI - MarketBeat
Danaher Euro Debt Raise Reshapes Masimo Deal And Valuation Story - Yahoo Finance
€2.98B Danaher (NYSE: DHR) euro notes to support Masimo acquisition - Stock Titan
Danaher to buy medical tech firm Masimo for $9.9 billion - MSN
Finanzdaten der Masimo Corp-Aktie (MASI)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.35%
2.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):